Evaluating Different Dosing Schemes for Aspirin Therapy
Author Information
Author(s): Meves Saskia H, Neubauer Horst, Overbeck Ursula, Endres Heinz G
Primary Institution: Ruhr University Bochum
Hypothesis
What is the best way to initiate antiplatelet therapy with aspirin for rapid effect?
Conclusion
The study shows that intravenous aspirin provides a quicker antiplatelet effect compared to oral doses.
Supporting Evidence
- Intravenous 500 mg aspirin achieved sufficient platelet inhibition within 30 seconds.
- Oral 500 mg aspirin took an average of 74 minutes to show an effect.
- 200 mg oral aspirin resulted in a delayed response of up to 11.2 hours.
Takeaway
This study tested how different ways of taking aspirin affect how quickly it works to stop blood from clotting. It found that getting aspirin through an IV works much faster than taking it by mouth.
Methodology
The study used a crossover design with 12 healthy volunteers receiving three different aspirin dosing regimens and measured platelet aggregation using whole blood aggregometry.
Potential Biases
The study was uncontrolled and used a small, homogeneous sample, which may not reflect broader patient populations.
Limitations
The study had a small sample size and only included healthy volunteers, which may not represent the response in acute stroke patients.
Participant Demographics
12 healthy volunteers (6 male, 6 female; mean age 34.8 years)
Statistical Information
P-Value
0.0045
Confidence Interval
95%
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website